Compass Pathways to Participate in Cowen Psychedelics and Novel Mechanisms in Neuropsychiatry Summit
LONDON & NEW YORK--(BUSINESS WIRE)-- Compass Pathways plc (CMPS) (“Compass”), a biotechnology company dedicated to accelerating access to evidence-based innovation in mental health, announced today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback